| Inflammasome and α-synuclein in Parkinson's disease: a cross-sectional study K Chatterjee, A Roy, R Banerjee, S Choudhury, B Mondal, S Halder, ... Journal of neuroimmunology 338, 577089, 2020 | 88 | 2020 |
| The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies K Chatterjee, P Das, NR Chattopadhyay, S Mal, T Choudhuri Heliyon 5 (11), 2019 | 40 | 2019 |
| Higher incidence of nasopharyngeal carcinoma in some regions in the world confers for interplay between genetic factors and external stimuli NR Chattopadhyay, P Das, K Chatterjee, T Choudhuri Drug discoveries & therapeutics 11 (4), 170-180, 2017 | 34 | 2017 |
| Clinical characterization of genetically diagnosed cases of spinocerebellar ataxia type 12 from India S Choudhury, S Chatterjee, K Chatterjee, R Banerjee, J Humby, B Mondal, ... Movement disorders clinical practice 5 (1), 39-46, 2018 | 26 | 2018 |
| Dance movement therapy in rehabilitation of Parkinson's disease–A feasibility study S Lihala, S Mitra, S Neogy, N Datta, S Choudhury, K Chatterjee, B Mondal, ... Journal of bodywork and movement therapies 26, 12-17, 2021 | 22 | 2021 |
| Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA B Mondal, S Choudhury, R Banerjee, K Chatterjee, S Ghosal, SS Anand, ... Annals of Movement Disorders 2 (1), 21-27, 2019 | 14 | 2019 |
| Association of p53 codon72 Arg> Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case–control study and meta-analysis SK Sahu, S Chakrabarti, SD Roy, N Baishya, RR Reddy, S Suklabaidya, ... Oncogenesis 5 (5), e225-e225, 2016 | 13 | 2016 |
| Levosulpiride-induced movement disorders S Choudhury, K Chatterjee, R Singh, S Shubham, S Trivedi, S Chatterjee, ... Journal of Pharmacology and Pharmacotherapeutics 8 (4), 177-181, 2017 | 12 | 2017 |
| Slowed movement stopping in Parkinson’s disease and focal dystonia is improved by standard treatment S Choudhury, A Roy, B Mondal, R Singh, S Halder, K Chatterjee, ... Scientific Reports 9 (1), 19504, 2019 | 10 | 2019 |
| Evolutionary aspects of Parvovirus B-19V associated diseases and their pathogenesis patterns with an emphasis on vaccine development P Das, K Chatterjee, NR Chattopadhyay, T Choudhuri Virusdisease 30, 32-42, 2019 | 10 | 2019 |
| Mirror movements in Parkinson's disease: An under-appreciated clinical sign P Chatterjee, R Banerjee, S Choudhury, B Mondal, MU Kulsum, ... Journal of the Neurological Sciences 366, 171-176, 2016 | 9 | 2016 |
| Novel inflammasome and oxidative modulators in Parkinson’s disease: a prospective study A Roy, R Banerjee, S Choudhury, K Chatterjee, B Mondal, S Dey, ... Neuroscience letters 786, 136768, 2022 | 7 | 2022 |
| Do peripheral immune and neurotrophic markers correlate with motor severity of Parkinson's disease? A Roy, B Mondal, R Banerjee, S Choudhury, K Chatterjee, S Dey, ... Journal of Neuroimmunology 354, 577545, 2021 | 7 | 2021 |
| Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters N Roy Chattopadhyay, K Chatterjee, A Banerjee, T Choudhuri VirusDisease 31 (4), 479-489, 2020 | 6 | 2020 |
| Role of Interleukin 28B polymorphisms in response to Interferon based therapy for hepatitis C virus clearance M Asthana, SK Sahu, A Kumar, S Mohanty, S Chakrabarti, P Das, ... Current Drug Metabolism 19 (3), 215-223, 2018 | 6 | 2018 |
| The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies. Heliyon. 2019; 5 (11): e02624 K Chatterjee, P Das, NR Chattopadhyay, S Mal, T Choudhuri | 6 | |
| Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells P Das, G Brahmachari, K Chatterjee, T Choudhuri International Journal of Molecular Medicine 50 (3), 1-18, 2022 | 4 | 2022 |
| The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia MOC Anderson Brito da Silva,Jane Pennifold,Ben Henley,Koustav Chatterjee ... Epilepsia Open, 2021 | 4* | 2021 |
| Siblings with unusual presentation of early onset Parkinson's disease with dual heterozygous PARK2 and PARK 9 mutation K Chatterjee, S Choudhury, S Shubham, B Mondal, P Basu, H Kumar Parkinsonism & Related Disorders 52, 117-118, 2018 | 4 | 2018 |
| Therapeutic effect of non-invasive vagus nerve stimulation in gait disturbance and freezing in Parkinson’s disease patients B Mondal, S Choudhury, K Chatterjee, R Banerjee, S Shubham, M Baker, ... Parkinsonism & Related Disorders 46, e21, 2018 | 4 | 2018 |
